Enhanced induction of lymphokine-activated killer activity following a single dose of cisplatin in cancer patients

This publication has 14 references indexed in Scilit:

• Effect of cisplatin upon expression of in vivo immune tumor resistance
  Cancer Immunology, Immunotherapy, 1993
• Increased production of interleukin-1 and tumor necrosis factor by human monocytes treated in vitro with cisplatin or other biological response modifiers
  Immunology Letters, 1992
• Up-regulation of induction of lymphokine (IL-2)-activated killer (LAK) cell activity by FK-565 and cisplatin
  Immunology Letters, 1991
• In Vitro and In Vivo Effects of Cisplatin on the Generation of Lymphokine-Activated Killer Cells
  JNCI Journal of the National Cancer Institute, 1990
• Augmentation of the generation of lymphokine-activated killer cells after a single dose of mitomycin C in cancer patients
  Cancer Immunology, Immunotherapy, 1989
• Up‐ and down‐regulation of human lymphokine (IL‐2)‐activated killer cell induction by monocytes, depending on their functional state
  International Journal of Cancer, 1988
• A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone
  New England Journal of Medicine, 1987
• The effects of dichloro-trans-dihydroxy-bis-isopropyl-amine-platinum IV on the primary cell-mediated cytotoxic response
  Immunopharmacology, 1983
• Translation of interleukin 2 mRNA from human peripheral blood leukocytes in Xenopus oocytes
  Biochemical and Biophysical Research Communications, 1982
• DEFECTIVE MONOCYTE KILLING IN PATIENTS WITH MALIGNANCIES AND RESTORATION OF FUNCTION DURING CHEMOTHERAPY
  The Lancet, 1980